Artelo Biosciences (ARTL) Interest & Investment Income (2020 - 2025)
Artelo Biosciences (ARTL) posted quarterly Interest & Investment Income of $5000.0 for Q3 2025, up 400.0% quarter-over-quarter from $1000.0 in Q2 2025.
Artelo Biosciences (ARTL) Interest & Investment Income (2020 - 2025) Analysis & Trends
Artelo Biosciences (ARTL) has reported Interest & Investment Income for 4 consecutive years, with $5000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Interest & Investment Income changed N/A year-over-year to $5000.0; the TTM figure through Sep 2025 stood at $13000.0 (changed N/A YoY), while the FY2022 annual figure was $2000.0, changed 0.0% from the prior year.
- Interest & Investment Income grew to $5000.0 in Q3 2025 per ARTL's latest filing, from $1000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $7000.0 in Q1 2025 and bottomed at $253.0 in Q1 2021.
- Historically, Interest & Investment Income has averaged $1965.7 across 3 years, with a median of $1000.0 in 2021.
- On a YoY basis, Interest & Investment Income climbed as much as 211.76% in 2021 and fell as far as 37.99% in 2021.
- Artelo Biosciences' Interest & Investment Income stood at $1000.0 in 2021, then changed by 0.0% to $1000.0 in 2022, then soared by 400.0% to $5000.0 in 2025.
- Business Quant data shows ARTL's Interest & Investment Income at $5000.0 in Q3 2025, $1000.0 in Q2 2025, and $7000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 67.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 27.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 28.14 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 115.94 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 10.98 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 5.13 Mn |
| 10 | Artelo Biosciences | 107,735.40 | -492,264.60 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Jun 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Nov 30, 2021 | 1,000.00 |
| Aug 31, 2021 | 802.00 |
| May 31, 2021 | 636.00 |
| Feb 28, 2021 | 253.00 |
| Nov 30, 2020 | 1,000.00 |
| May 31, 2020 | 204.00 |
| Feb 29, 2020 | 408.00 |